Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.200
+0.060 (5.26%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Marker Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
133349237970
Upgrade
Market Cap Growth
-31.89%-31.89%115.29%-71.23%13.36%-47.12%
Upgrade
Enterprise Value
-72431124255
Upgrade
Last Close Price
1.143.115.502.669.5014.50
Upgrade
PS Ratio
1.555.0514.776.4663.58149.18
Upgrade
PB Ratio
0.661.793.481.161.802.55
Upgrade
P/TBV Ratio
1.791.793.481.161.802.55
Upgrade
EV/Sales Ratio
3.693.699.493.5234.02117.63
Upgrade
Debt / Equity Ratio
----0.270.45
Upgrade
Asset Turnover
0.340.340.130.070.020.01
Upgrade
Quick Ratio
6.226.225.251.823.283.49
Upgrade
Current Ratio
6.366.365.572.143.563.81
Upgrade
Return on Equity (ROE)
-65.81%-65.81%-83.47%-62.20%-117.42%-80.37%
Upgrade
Return on Assets (ROA)
-35.50%-35.50%-35.36%-24.12%-43.38%-39.26%
Upgrade
Return on Capital (ROIC)
-42.62%-42.62%-54.16%-32.79%-51.70%-42.90%
Upgrade
Earnings Yield
-87.90%-32.23%-16.85%-131.80%-53.05%-41.22%
Upgrade
FCF Yield
-89.37%-32.76%-33.63%-118.78%-38.52%-42.06%
Upgrade
Buyback Yield / Dilution
-1.94%-1.94%-5.49%-9.16%-62.64%-3.19%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q